Panel Discussion: Rationalizing the CQAs of Polymer Delivery Vehicles to Promote Batch to Batch Consistency, Reducing Regulatory Scrutiny

Time: 12:15 pm
day: Conference Day Two


  • Distinguishing the current critical quality attributes industry and academia are utilising to assess the potency of the drug product
  • Determining how important the size of the polymeric molecule could prove to be in the delivery of the API
  • Comparing drug products to understand CQAs which remain a constant for regulators and areas which creates variability